Bessemer Group’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-26,300	Closed	-$1.25M	–	1792
2020 Q2	$1.25M	Buy	+26,300	New	+$1.25M	﹤0.01%	648